Clinical significance of urine MCP-1 determination in patients with lupus nephritis
Shi Yong-ju
Abstract
Shi Yong-ju
Abstract
Objective To explore the clinical significance of urine monocyte chemoattractant protein-1 (MCP-1) in patients with lupus nephritis (LN). Methods Urine MCP-1 was detected by Enzyme-linked immunosorbent assay (ELISA). Correlation analysis of urine MCP-1 and renal injury, urine MCP-1 and the activity indices of renal histopathologic change were evaluated. Results Urine MCP-1 level in LN patients (1130±403) pg/mg Cr was significantly higher than that of normal controls (141±109) pg/(mgCr) (P0.01) and primary nephritis patients (452±174) pg/mg Cr (P0.01). Urine MCP-I was significantly correlated with proteinuria (r=0.558, P0.05), serum creatinine level (r=0.869, P0.01), urine NAG (r=0.617, P0.05) and the activity indices (AI) of renal histopathologic change (r=0.751, P0.01). Conclusion Urine MCP-1 can be used as a molecular maker to evaluate disease activity of patients with lupus nephritis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the clinical significance of urine monocyte chemoattractant protein-1 (MCP-1) in patients with lupus nephritis (LN). Methods Urine MCP-1 was detected by Enzyme-linked immunosorbent assay (ELISA). Correlation analysis of urine MCP-1 and renal injury, urine MCP-1 and the activity indices of renal histopathologic change were evaluated. Results Urine MCP-1 level in LN patients (1130±403) pg/mg Cr was significantly higher than that of normal controls (141±109) pg/(mgCr) (P0.01) and primary nephritis patients (452±174) pg/mg Cr (P0.01). Urine MCP-I was significantly correlated with proteinuria (r=0.558, P0.05), serum creatinine level (r=0.869, P0.01), urine NAG (r=0.617, P0.05) and the activity indices (AI) of renal histopathologic change (r=0.751, P0.01). Conclusion Urine MCP-1 can be used as a molecular maker to evaluate disease activity of patients with lupus nephritis.
Key concepts: Urine, Lupus nephritis, Medicine, Proteinuria, Nephritis, Internal medicine, Creatinine, Clinical significance